The NIH Studied COVID-19 Vaccine Injured in 2021—What Happened to Their Treatment?

Americans who developed neurological complications from the COVID-19 vaccines are not being compensated by the government because the U.S. Food and Drug Administration (FDA) does not recognize these as safety signals.

“If they fail to recognize all these neurological complications, then the Department of Health and Human Services, through the CICP (Countermeasures Injury Compensation Program), is going to deny everybody that [doesn’t have] anaphylaxis, myocarditis, and blood clotting disorders,” said Dr. Joel Wallskog, founder of React19, a nonprofit that is supporting people injured by the COVID-19 shots.

Meanwhile, Dr. Wallskog said that another federal health branch—the National Institutes of Health (NIH)—is allegedly withholding an important study that could convince the FDA to recognize neurological events and widen the compensation window.

“Early on with the shot rollout, there were a lot of people [with] neurological complications. [The NIH] flew in 23 people, they studied them all, they developed a treatment program.

“They told these 23 people that they would investigate, and they would communicate this to the broader population. But somewhere in 2022, that communication with the 23 [people] just ended,” said Dr. Wallskog.

He believes the NIH never communicated their findings to the FDA.

“It’s insane. We know through React19 that the adverse neurological events are probably the most common adverse event,” he said.

React19 is a leading nonprofit organization that is supporting Americans injured by the COVID-19 shots.

To this day, they have awarded 81 grants to adults and children, totaling $562,000.

“Now compare that to our government. They’ve given out three grants to injured people, for an average of $1,500 and a total of $4,500.”

PODCAST TRANSCRIPT:

coming soon